Health and Wellness

The company will use the funds for a European feasibility study for its transcatheter device and for the launch of a U.S.-based clinical study.  

The company will use the funds for a European feasibility study for its transcatheter device and for the launch of a U.S.-based clinical study.

The Swiss company’s over-the-counter wrist wearable, which uses optical sensors to gather blood pressure readings, will be available to U.S. consumers in 2026.

Technological innovation has the power and promise to transform healthcare. This series spotlights companies developing such cutting-edge innovations—ranging from brain-computer and muscle-machine interfaces to 3D-printed breast bioprostheses and beyond.

The company's platform aims to help commercial and medical affairs teams automate manual and rote tasks.  

Astrana Health completes a $708 million acquisition that it announced in 2024.   

The wristband is designed to alleviate essential tremors by modulating the nervous system and restoring motor control.

The acquisition is expected to boost Teleflex's global footprint in the peripheral intervention market.   

The AI-based early warning system the NHS is developing is part of the government's 10 Year Health Plan to use data to identify patient safety concerns.